Using non-wearable devices to check breathing during sleep in people with schizophrenia
Checks sleep breathing problems in hospitalized adults with schizophrenia using non-wearable devices.
Plain-language title generated from the registry record
Registry title: Investigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With Schizophrenia
Key facts
- Where
- New Taipei City, TaiwanSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for hospitalized adults aged 20 to 70 with a schizophrenia spectrum disorder who are in a fairly stable condition. Sleep breathing is assessed with devices that are not worn.
- Age
- 20 to 70 years
- Sex
- Women and men can both join.
- Disease stage
- Schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder or schizophreniform disorder), diagnosed by DSM-5 criteria and confirmed with the MINI 7.0 (Chinese version). Fairly stable condition at admission.
- Earlier treatment
- People currently using CPAP therapy for sleep apnea cannot join.
Main reasons for not taking part
- Currently receiving continuous positive airway pressure (CPAP) therapy for sleep apnea
- Another serious condition affecting the central nervous system, such as major depressive disorder or bipolar disorder
- Serious medical illness, such as a malignant tumor, end-stage heart or lung disease, a neuromuscular disorder, or uncontrolled epileptic seizures
- Cannot sleep lying on the back because of a serious medical condition
- Judged unsuitable by the clinical team, for example because of agitation or not cooperating
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 70 years old?
Source: NCT07192042, who can take part
Where in Taiwan
- Ministry of Health and Welfare Shuang-Ho HospitalNew Taipei City, TaiwanContact: Jiunn-Kae Wang, MD, MScTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Taipei Medical University Shuang Ho Hospital
- Trial code
- NCT07192042
- Record updated
- 28 August 2026
- Original description
This research project aims to evaluate the prevalence of comorbid OSA and its impact on disease progression among hospitalized schizophrenia patients using non-wearable devices.Read full original descriptionShow less
Investigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With Schizophrenia
This research project aims to evaluate the prevalence of comorbid OSA and its impact on disease progression among hospitalized schizophrenia patients using non-wearable devices.
Inclusion: Age: Participants must be between 20 and 70 years old; Diagnostic Criteria: Schizophrenia spectrum disorders, including schizophrenia, schizoaffective disorder, and schizophreniform disorder, diagnosed according to DSM-5 criteria and confirmed with the MINI 7.0 (Chinese version); Clinical Stability and Informed Consent: At the time of admission, participants should be in a relatively stable condition, able to understand the study procedures, and capable of providing written informed consent. If patients are unable to fully comprehend due to illness severity or cognitive limitations, consent may be obtained from a legal guardian or family member, with subsequent confirmation of consent by the patient once their condition improves.
Exclusion: Treatment-related: Patients who are currently receiving continuous positive airway pressure (CPAP) therapy for OSA; Other Major Central Nervous System Disorders: Presence of other serious conditions that may significantly affect central nervous system function, aside from schizophrenia, such as major depressive disorder or bipolar disorder; Severe Medical Illnesses: Including, but not limited to, malignant tumors, end-stage cardiopulmonary disease, neuromuscular disorders severely affecting motor or respiratory function, uncontrolled epileptic seizures, or other serious medical conditions that prevent patients from sleeping in the supine position; Clinical Judgment: Patients deemed unsuitable for participation due to clinical conditions (e.g., agitation, non-cooperation, or other safety concerns).